September 7, 2023 - Patient Worthy

Source: Pixabay.com

Orphan Drug Designation Granted to Three Active Moieties of INT230-6 for Soft Tissue Sarcoma (STS)

Post author:Jessica Lynn
Post published:September 7, 2023
Post category:Soft Tissue Sarcoma

INT230-6, developed by clinical-stage biotechnology company Intensity Therapeutics (“Intensity”), is an investigational therapy comprising three moieties: cisplatin, SHAO-FA (a penetration enhancing molecule), and vinblastine sulfate. A moiety, in this sense,…

source: pixabay.com

Positive Signs from Interim Data in Early Hepatocellular Carcinoma Trial

Post author:James Moore
Post published:September 7, 2023
Post category:Hepatocellular Carcinoma

According to a story from PR Newswire, the pharma company Medivir AB, which is focused on developing cancer therapies in areas of critical high unmet need, recently announced the release…

source: pixabay.com

Patients and Doctors Are Pressuring Health Insurance Companies Online in Order to Receive Proper Treatment

Post author:Rose Duesterwald
Post published:September 7, 2023
Post category:Rare Disease

Social media has become a vehicle for customer complaints and the companies are listening. Estimates are that almost two-thirds of dissatisfied customers have received a response to their online…

Glofitamab with Obinutuzumab Shows Promise in Heavily Pretreated Richter Syndrome

Post author:Jessica Lynn
Post published:September 7, 2023
Post category:Chronic Lymphocytic Leukemia Richter syndrome

Also known as Richter’s Transformation, Richter syndrome is a rare and aggressive complication of chronic lymphocytic leukemia (CLL). When someone develops Richter syndrome, their CLL can transform into another rare…

Lila’s Journey: Staying Positive While Living With Pediatric Low-Grade Glioma (pLGG)

Post author:Patient Worthy Contributor
Post published:September 7, 2023
Post category:Pediatric Low-grade Glioma

Acknowledgment: This story is sponsored by Day One Biopharmaceuticals and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant,…

Orphan Drug Designation Granted to Three Active Moieties of INT230-6 for Soft Tissue Sarcoma (STS)

Positive Signs from Interim Data in Early Hepatocellular Carcinoma Trial

Patients and Doctors Are Pressuring Health Insurance Companies Online in Order to Receive Proper Treatment

Glofitamab with Obinutuzumab Shows Promise in Heavily Pretreated Richter Syndrome

Lila’s Journey: Staying Positive While Living With Pediatric Low-Grade Glioma (pLGG)

Rethinking What It Means to Live With Acromegaly

The Let’s Chat CAR T One-on-One Mentor Program: Speaking with Someone Who Understands What You Are Going Through

“Shades of Psoriasis”: Plaque Psoriasis and Sharing Your Story

Understanding RSV: Why Combatting Ethnic and Age-Related Health Disparities Could Improve Outcomes

We Need Equity and Diversity Within Rare Disease Research

DNA in Color: How Ronya Nelson is Working to Close the Diversity Gap in Genetics - Part 1

Bridging the Diversity Gap in Healthcare

Congratulations to the 2023 Recipients of the Diversity in Lupus Research Awards!

Welcome to Study of the Week. We go in-depth and select a study we think is of particular interest, discussing details, explaining its importance, who may be impacted and lots more!

Let’s Work Together!

Keep Up to Date

Learn More